PODCAST · health
The ARTNet Podcast
by NCI ARTNet
Why do cancer treatments work for some patients at first, only to stop working later? In the premiere episode of the ARTNet Podcast, we speak with Dr. Jeffrey Tyner from Oregon Health & Science University about the complex biology behind acquired resistance to cancer therapies.Dr. Tyner shares insights into how cancer cells adapt and survive treatment, the critical role of the tumor microenvironment, and why understanding resistance mechanisms is essential for developing more durable therapies. The conversation also explores how collaboration across the ARTNet Consortium is helping researchers connect data, models, and expertise to better understand cancer relapse and treatment failure.From leukemia research to large-scale data sharing, this episode offers an inside look at one of the biggest challenges in modern oncology — and the scientific efforts underw
-
1
Why Cancer Fights Back: A Conversation with Jeffrey Tyner
FeaturingJeffrey TynerProfessor, Oregon Health & Science UniversityPrinciple Investigator, ARTNet AML U54 CenterDr. Tyner is a leading researcher in cancer biology and therapeutic resistance, with a focus on acute myeloid leukemia (AML), functional precision oncology, and mechanisms of acquired resistance to targeted therapies.Hosted byDavid GoodrichProfessor, Roswell Park Comprehensive Cancer CenterARTNet Coordinating and Data Management CenterDr. Goodrich leads discussions exploring the science, collaboration, and translational impact of cancer resistance research across the ARTNet Consortium.Episode SummaryThe conversation explores the complexity of acquired resistance in cancer therapy, emphasizing the role of cell state and cellular plasticity in driving resistance mechanisms. Dr. Tyner discusses the challenges of studying dynamic resistance processes, the promise of targeting cell state plasticity to overcome therapeutic failure, and how resistance trajectories evolve over time.The discussion also highlights the importance of identifying the optimal window for intervention and the growing role of collaborative science within the ARTNet Consortium in advancing cancer resistance research. Despite the complexity of the problem, the episode reflects a strong sense of optimism about the future of precision oncology and translational cancer research.Key TakeawaysAcquired resistance is a dynamic and evolving process in cancer therapyCell state plasticity plays a central role in therapeutic resistanceResistance mechanisms can differ across patients and tumor contextsUnderstanding resistance trajectories may reveal new therapeutic opportunitiesCollaborative research and data sharing are essential for advancing precision oncologyChapters00:00 Introduction to ARTNet Consortium05:15 From Targeted Therapy to Tumor Complexity10:15 Understanding Acquired Resistance and Tumor Evolution19:50 Cell State Plasticity and Therapeutic Resistance24:05 Resistance Trajectories and Future Treatment Strategies29:00 The Future of Precision Oncology and the Role of ARTNet
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Why do cancer treatments work for some patients at first, only to stop working later? In the premiere episode of the ARTNet Podcast, we speak with Dr. Jeffrey Tyner from Oregon Health & Science University about the complex biology behind acquired resistance to cancer therapies.Dr. Tyner shares insights into how cancer cells adapt and survive treatment, the critical role of the tumor microenvironment, and why understanding resistance mechanisms is essential for developing more durable therapies. The conversation also explores how collaboration across the ARTNet Consortium is helping researchers connect data, models, and expertise to better understand cancer relapse and treatment failure.From leukemia research to large-scale data sharing, this episode offers an inside look at one of the biggest challenges in modern oncology — and the scientific efforts underw
HOSTED BY
NCI ARTNet
Loading similar podcasts...
Frequently Asked Questions
How many episodes does The ARTNet Podcast have?
The ARTNet Podcast currently has 1 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is The ARTNet Podcast about?
Why do cancer treatments work for some patients at first, only to stop working later? In the premiere episode of the ARTNet Podcast, we speak with Dr. Jeffrey Tyner from Oregon Health & Science University about the complex biology behind acquired resistance to cancer therapies.Dr. Tyner shares...
How often does The ARTNet Podcast release new episodes?
The ARTNet Podcast has 1 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to The ARTNet Podcast?
You can listen to The ARTNet Podcast on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts The ARTNet Podcast?
The ARTNet Podcast is created and hosted by NCI ARTNet.
URL copied to clipboard!